ZAPPAVIGNA, Silvia
ZAPPAVIGNA, Silvia
Dipartimento di Medicina di Precisione
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.
2012 Lamberti, Monica; Porto, S; Marra, M; Zappavigna, S; Grimaldi, A; Feola, D; Pesce, D; Naviglio, Silvio; Spina, Annamaria; Sannolo, Nicola; Caraglia, Michele
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma
2019 Zappavigna, S.; Cossu, A. M.; Abate, M.; Misso, G.; Lombardi, A.; Caraglia, M.; Filosa, R.
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives.
2014 Lamberti, Monica; Porto, S; Zappavigna, S; Addeo, E; Marra, M; Miraglia, Nadia; Sannolo, Nicola; Vanacore, D; Stiuso, Paola; Caraglia, Michele
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells
2022 Luce, Amalia; Lombardi, Angela; Ferri, Carmela; Zappavigna, Silvia; Tathode, Madhura S; Miles, Amanda K; Boocock, David J; Vadakekolathu, Jayakumar; Bocchetti, Marco; Alfano, Roberto; Sperlongano, Rossella; Ragone, Angela; Sapio, Luigi; Desiderio, Vincenzo; Naviglio, Silvio; Regad, Tarik; Caraglia, Michele
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers.
2014 Lamberti, Monica; Zappavigna, S; Sannolo, Nicola; Porto, S; Caraglia, Michele
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx
2017 Ricciardiello, Filippo; Caraglia, Michele; Iorio, Brigida; Abate, Teresa; Boccellino, Mariarosaria; Colella, Giuseppe; Oliva, Flavia; Ferrise, Pierpaolo; Zappavigna, Silvia; Faenza, Mario; Ferraro, Giuseppe A.; Sequino, Giulio; Nicoletti, Giovanni Francesco; Mesolella, Massimo
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells
2015 Grimaldi, Anna; Santini, D.; Zappavigna, S.; Lombardi, A.; Misso, Gabriella; Boccellino, Mariarosaria; Desiderio, Vincenzo; Vitiello, P. P.; DI LORENZO, Giuseppe; Zoccoli, A.; Pantano, F.; Caraglia, Michele
Anti-inflammatory drugs as anticancer agents
2020 Zappavigna, S.; Cossu, A. M.; Grimaldi, A.; Bocchetti, M.; Ferraro, G. A.; Nicoletti, G. F.; Filosa, R.; Caraglia, M.
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures
2019 Della Corte, C. M.; Barra, G.; Ciaramella, V.; Di Liello, R.; Vicidomini, G.; Zappavigna, S.; Luce, A.; Abate, M.; Fiorelli, A.; Caraglia, M.; Santini, M.; Martinelli, E.; Troiani, T.; Ciardiello, F.; Morgillo, F.
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
2021 Di Lorenzo, G.; Zappavigna, S.; Crocetto, F.; Giuliano, M.; Ribera, D.; Morra, R.; Scafuri, L.; Verde, A.; Bruzzese, D.; Iaccarino, S.; Costabile, F.; Onofrio, L.; Viggiani, M.; Palmieri, A.; De Placido, P.; Marretta, A. L.; Pietroluongo, E.; Luce, A.; Abate, M.; Navaeiseddighi, Z.; Caputo, V. F.; Celentano, G.; Longo, N.; Ferro, M.; Morelli, F.; Facchini, G.; Caraglia, M.; De Placido, S.; Buonerba, C.
Autophagic cell death: A new frontier in cancer research
2013 Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M.
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress.
2008 Marra, M.; Lombardi, A.; Agostinelli, E.; Giuberti, G.; Zappavigna, S.; Tempera, G.; Vitale, G.; Bifulco, M.; ABBRUZZESE SACCARDI, A.; Caraglia, Michele
Characterization of KRAS Mutational Regression in Oligometastatic Patients
2022 Ottaiano, Alessandro; de Vera d'Aragona, Roberta Penta; Trotta, Anna Maria; Santorsola, Mariachiara; Napolitano, Maria; Scognamiglio, Giosuè; Tatangelo, Fabiana; Grieco, Paolo; Zappavigna, Silvia; Granata, Vincenza; Perri, Francesco; Luce, Amalia; Savarese, Giovanni; Ianniello, Monica; Casillo, Marika; Petrillo, Nadia; Belli, Andrea; Izzo, Francesco; Nasti, Guglielmo; Caraglia, Michele; Scala, Stefania
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
2013 Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele
Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance
2018 Giarra, S.; Zappavigna, S.; Campani, V.; Abate, M.; Cossu, A. M.; Leonetti, C.; Porru, M.; Mayol, L.; Caraglia, M.; De Rosa, G.
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms
2012 Ferro, M; Giuberti, G; Zappavigna, S; Perdonà, S; Facchini, G; Sperlongano, Pasquale; Porto, S; Di Lorenzo, G; Buonerba, C; Abbruzzese, A; Altieri, V; Caraglia, Michele
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy?
2013 Dicitore, A; Caraglia, Michele; Colao, A; Zappavigna, S; Mari, D; Hofland, Lj; Persani, L; Vitale, G.
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy
2008 Caraglia, ; M, ; Marra, ; M, ; Meo, ; G, ; Addeo, ; Sr, ; Vincenzi, ; B, ; Baldi, ; A, ; Zappavigna, S; Rosolowski, ; M, ; Loeffler, ; B, ; Budillon, ; A, ; Tonini, ; G, ; Santini, ; D,
CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY
2008 Caraglia, ; M, ; Marra, ; M, ; Meo, ; G, ; Zappavigna, S; Vincenzi, ; B, ; Baldi, ; A, ; Rosolowski, ; Loeffler, ; M, ; Tonini, ; G, ; Santini, ; D, ; Budillon, ; A,
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells
2009 Marra, M; Santini, D; Meo, G; Vincenzi, B; Zappavigna, S; Baldi, Alfonso; Rosolowski, M; Tonini, G; Loeffler, M; Lupu, R; Addeo, Sr; Abbruzzese, A; Budillon, A; Caraglia, Michele
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. | 1-gen-2012 | Lamberti, Monica; Porto, S; Marra, M; Zappavigna, S; Grimaldi, A; Feola, D; Pesce, D; Naviglio, Silvio; Spina, Annamaria; Sannolo, Nicola; Caraglia, Michele | |
| A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma | 1-gen-2019 | Zappavigna, S.; Cossu, A. M.; Abate, M.; Misso, G.; Lombardi, A.; Caraglia, M.; Filosa, R. | |
| A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. | 1-gen-2014 | Lamberti, Monica; Porto, S; Zappavigna, S; Addeo, E; Marra, M; Miraglia, Nadia; Sannolo, Nicola; Vanacore, D; Stiuso, Paola; Caraglia, Michele | |
| A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells | 1-gen-2022 | Luce, Amalia; Lombardi, Angela; Ferri, Carmela; Zappavigna, Silvia; Tathode, Madhura S; Miles, Amanda K; Boocock, David J; Vadakekolathu, Jayakumar; Bocchetti, Marco; Alfano, Roberto; Sperlongano, Rossella; Ragone, Angela; Sapio, Luigi; Desiderio, Vincenzo; Naviglio, Silvio; Regad, Tarik; Caraglia, Michele | |
| Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. | 1-gen-2014 | Lamberti, Monica; Zappavigna, S; Sannolo, Nicola; Porto, S; Caraglia, Michele | |
| Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx | 1-gen-2017 | Ricciardiello, Filippo; Caraglia, Michele; Iorio, Brigida; Abate, Teresa; Boccellino, Mariarosaria; Colella, Giuseppe; Oliva, Flavia; Ferrise, Pierpaolo; Zappavigna, Silvia; Faenza, Mario; Ferraro, Giuseppe A.; Sequino, Giulio; Nicoletti, Giovanni Francesco; Mesolella, Massimo | |
| Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells | 1-gen-2015 | Grimaldi, Anna; Santini, D.; Zappavigna, S.; Lombardi, A.; Misso, Gabriella; Boccellino, Mariarosaria; Desiderio, Vincenzo; Vitiello, P. P.; DI LORENZO, Giuseppe; Zoccoli, A.; Pantano, F.; Caraglia, Michele | |
| Anti-inflammatory drugs as anticancer agents | 1-gen-2020 | Zappavigna, S.; Cossu, A. M.; Grimaldi, A.; Bocchetti, M.; Ferraro, G. A.; Nicoletti, G. F.; Filosa, R.; Caraglia, M. | |
| Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures | 1-gen-2019 | Della Corte, C. M.; Barra, G.; Ciaramella, V.; Di Liello, R.; Vicidomini, G.; Zappavigna, S.; Luce, A.; Abate, M.; Fiorelli, A.; Caraglia, M.; Santini, M.; Martinelli, E.; Troiani, T.; Ciardiello, F.; Morgillo, F. | |
| Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide | 1-gen-2021 | Di Lorenzo, G.; Zappavigna, S.; Crocetto, F.; Giuliano, M.; Ribera, D.; Morra, R.; Scafuri, L.; Verde, A.; Bruzzese, D.; Iaccarino, S.; Costabile, F.; Onofrio, L.; Viggiani, M.; Palmieri, A.; De Placido, P.; Marretta, A. L.; Pietroluongo, E.; Luce, A.; Abate, M.; Navaeiseddighi, Z.; Caputo, V. F.; Celentano, G.; Longo, N.; Ferro, M.; Morelli, F.; Facchini, G.; Caraglia, M.; De Placido, S.; Buonerba, C. | |
| Autophagic cell death: A new frontier in cancer research | 1-gen-2013 | Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M. | |
| Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. | 1-gen-2008 | Marra, M.; Lombardi, A.; Agostinelli, E.; Giuberti, G.; Zappavigna, S.; Tempera, G.; Vitale, G.; Bifulco, M.; ABBRUZZESE SACCARDI, A.; Caraglia, Michele | |
| Characterization of KRAS Mutational Regression in Oligometastatic Patients | 1-gen-2022 | Ottaiano, Alessandro; de Vera d'Aragona, Roberta Penta; Trotta, Anna Maria; Santorsola, Mariachiara; Napolitano, Maria; Scognamiglio, Giosuè; Tatangelo, Fabiana; Grieco, Paolo; Zappavigna, Silvia; Granata, Vincenza; Perri, Francesco; Luce, Amalia; Savarese, Giovanni; Ianniello, Monica; Casillo, Marika; Petrillo, Nadia; Belli, Andrea; Izzo, Francesco; Nasti, Guglielmo; Caraglia, Michele; Scala, Stefania | |
| Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. | 1-gen-2013 | Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele | |
| Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance | 1-gen-2018 | Giarra, S.; Zappavigna, S.; Campani, V.; Abate, M.; Cossu, A. M.; Leonetti, C.; Porru, M.; Mayol, L.; Caraglia, M.; De Rosa, G. | |
| Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms | 1-gen-2012 | Ferro, M; Giuberti, G; Zappavigna, S; Perdonà, S; Facchini, G; Sperlongano, Pasquale; Porto, S; Di Lorenzo, G; Buonerba, C; Abbruzzese, A; Altieri, V; Caraglia, Michele | |
| Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? | 1-gen-2013 | Dicitore, A; Caraglia, Michele; Colao, A; Zappavigna, S; Mari, D; Hofland, Lj; Persani, L; Vitale, G. | |
| CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy | 1-gen-2008 | Caraglia, ; M, ; Marra, ; M, ; Meo, ; G, ; Addeo, ; Sr, ; Vincenzi, ; B, ; Baldi, ; A, ; Zappavigna, S; Rosolowski, ; M, ; Loeffler, ; B, ; Budillon, ; A, ; Tonini, ; G, ; Santini, ; D, | |
| CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY | 1-gen-2008 | Caraglia, ; M, ; Marra, ; M, ; Meo, ; G, ; Zappavigna, S; Vincenzi, ; B, ; Baldi, ; A, ; Rosolowski, ; Loeffler, ; M, ; Tonini, ; G, ; Santini, ; D, ; Budillon, ; A, | |
| Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells | 1-gen-2009 | Marra, M; Santini, D; Meo, G; Vincenzi, B; Zappavigna, S; Baldi, Alfonso; Rosolowski, M; Tonini, G; Loeffler, M; Lupu, R; Addeo, Sr; Abbruzzese, A; Budillon, A; Caraglia, Michele |